Somaxon (SOMX +83%) soars this morning - after initially surging over 150% in pre-open trading -...

|About: Somaxon Pharmaceuticals, Inc. (SOMX)|By:, SA News Editor

Somaxon (SOMX +83%) soars this morning - after initially surging over 150% in pre-open trading - on the back of yesterday's announcement of its litigation settlement over Silenor with Mylan (MYL +0.8%) and Par Pharmaceuticals. The company added that it sees higher Q2 net sales for Silenor, now seeing revenue of approximately $2.8M to $2.9M, up from reported sales of $2.7M in Q1.